Health Care: Health Services

TearLab Corpoartion (TEAR: NASDAQ)

$10.07 -0.21 | -2.04%
05/24/13 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 10.07
52 Week High 10.40
52 Week Low 2.75
Avg. Daily Vol. (Mil) 0.37
Beta (3 year) 2.41
Share Related Items
Mkt Cap (Mil) 291.74
Shares Out (Mil) 28.97
Float (Mil) 25.38
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 0.90
Current Ratio 1.10
LT Debt/ Equity 0.00
Total Debt / Equity 1.76
Valuation Ratios
Price Earnings n.a.
Price/Sales 48.52
Price/Book 44.21
Price/Cash Flow -10.30
Per Share Data
Earnings -0.69
Sales 0.21
Book Value 0.23
Cash Flow -0.98
Business Summary
TearLab Corporation is an in-vitro diagnostic company. It commercializes a proprietary tear testing platform that enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film.
General Information
7360 Carroll Road
Suite 200
San Diego, CA 92121
www.tearlab.com
Industry : Health Services
Sector: Health Care
Employees: 48
CEO: Elias Vamvakas
Short Interest
Current Month (Mil) 5.44
Previous Month (Mil) 5.27
Short Interest Ratio (Days) 16.00
Management Effectiveness
Return on Equity n.a.
Return on Assets -135.80
Return on Investments -452.00
Profitability
Gross Margin 47.20
EBIT Margin n.a.
Profit Margin 0.00
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter